CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Income Statement [Abstract]
Net sales	$ 108,377	$ 132,410
Cost of sales	83,684	96,142
Gross profit	24,693	36,268
Research and development expenses	8,360	7,806
Selling, general and administrative expenses	26,782	29,023
Goodwill impairment	49,075	0
Operating income (loss)	(59,524)	(561)
Interest income (expense), net	(975)	(296)
Other income (expense), net	(214)	360
Income (loss) before provision for income taxes	(60,713)	(497)
Provision for income taxes	650	2,413
Net income (loss)	$ (61,363)	$ (2,910)
Earnings (loss) per share:
Basic (in dollars per share)	$ (4.81)	$ (0.23)
Diluted (in dollars per share)	$ (4.81)	$ (0.23)
Shares used in computing earnings (loss) per share:
Basic (in shares)	12,749	12,812
Diluted (in shares)	12,749	12,812